Feasibility of high intensity interval training in pulmonary rehabilitation programmes for patients with interstitial lung disease and preliminary efficacy of its long-term benefits

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN55846300

Enrollment

Registered

2014-06-05

Start date

2014-06-12

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Respiratory disorders

Interventions

HIIT in PR Active group: Patients in this group will train in a pulmonary rehabilitation programme using high-intensity interval training MICT in PR Control group: Patients in the control group will t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with varying severity of ILD (all types apart from sarcoidosis will be included). The type and severity of participants will be recorded 2. Patients whose first language is not English (we will provide interpreters to explain educational presentations and other instructions as per usual clinical practice)

Exclusion criteria

Exclusion criteria: 1. Patients with sarcoidosis 2. Patients with significant comorbidities (musculoskeletal, cardiac or neurological) that interfere with patients' ability to exercise

Design outcomes

Primary

Measure	Time frame
Exercise capacity: 6MWT; Timepoint(s): Pre-PR, Post-PR and 6 months after PR	—

Secondary

Measure	Time frame
1. Breathlessness; Timepoint(s): Pre-PR, Post-PR and 6 months post PR 2. Feasibility measures (recruitment/adherence/retention); Timepoint(s): Post-PR, 6 months later 3. Quality of Life questionnaires; Timepoint(s): Pre-PR, Post-PR and 6 months later 4. Respiratory and peripheral muscle function; Timepoint(s): Pre-PR, Post-PR and 6 months later 5. VO2max-CPET; Timepoint(s): Pre-PR, post-PR and 6 months later 6. In-depth interviews; Timepoint(s): Pre-PR, post-PR and 6 months later	—

Measure

Time frame

1. Breathlessness; Timepoint(s): Pre-PR, Post-PR and 6 months post PR 2. Feasibility measures (recruitment/adherence/retention); Timepoint(s): Post-PR, 6 months later 3. Quality of Life questionnaires; Timepoint(s): Pre-PR, Post-PR and 6 months later 4. Respiratory and peripheral muscle function; Timepoint(s): Pre-PR, Post-PR and 6 months later 5. VO2max-CPET; Timepoint(s): Pre-PR, post-PR and 6 months later 6. In-depth interviews; Timepoint(s): Pre-PR, post-PR and 6 months later

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 8, 2026